News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Thousands of Kiwis will benefit from advances in treatment

10 May 2018

Thousands of New Zealanders will benefit from advances in treatment

Thousands of New Zealanders will benefit from advances in treatment as a result of two PHARMAC funding decisions. The first decision is to fund a medication for treating a degenerative eye condition, and the second is to fund another oral anticoagulant option for the prevention of strokes and the prevention or treatment of blood clots.

Aflibercept (Eylea), which is used to treat degenerative eye conditions, will be funded from 1 June 2018 and will be available in both hospitals and the community.

“This is a new generation treatment that helps preserve and improve vision,” says PHARMAC Director of Operations, Lisa Williams.

“It increases treatment options for people with wet age-related macular degeneration and diabetic macular oedema – both of which are extremely common causes of blindness in New Zealand.”

Wet age-related macular degeneration is New Zealand’s most common cause of blindness, affecting one in seven people over the age of 50. Diabetic macular oedema is a serious complication of type 1 and 2 diabetes and is the leading cause of blindness in people aged 25–74.

“Aflibercept will provide more flexibility for patients and reduce the burden on DHB ophthalmology services as it requires less frequent injections than the current treatments, and will be funded whether prescribed by private or public ophthalmologists,” says Ms Williams.

“We expect this to have a positive impact on the wider health system, while providing a better treatment option for patients.”

Around 900 people are expected to benefit from this decision in the first year of funding.

The second funding decision will increase the number of patients able to access rivaroxaban (Xarelto), an anticoagulant used for preventing strokes and for preventing or treating blood clots. Previously, it was only funded for short periods following hip or knee replacement surgery.

“This decision, which takes effect from 1 August 2018, will remove restrictions on who can prescribe rivaroxaban along with the conditions that it can be used to treat,” says Ms Williams.

“This means there will be additional treatment options for patients who aren’t able to tolerate currently funded oral treatments such as warfarin and dabigatran. Rivaroxaban can usually be taken once a day , crushed for those unable to swallow tablets, is able to be compliance packed by pharmacists and generally requires less monitoring compared to warfarin.

Widening access to this medication could benefit up to 12,000 people in the first year of funding.”

More information is available in the notification on the PHARMAC website.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Ockhams: Pip Adam Wins Premier Book Award

A novel which judges say ‘will bring readers back from the dead’ has won the 2018 $50,000 Acorn Foundation Fiction Prize in the country’s premier book awards. More>>

ALSO:

Voyager Award Winner: “Sempy’s Xmas”

Congratulations to Kent Blechynden, who won a Voyager Media Award for this photo essay, published on Scoop in December.

Michael “Semp” Semple is an old school punk rocker from New Plymouth who is on the methadone programme... On Christmas day he thought he would be alone but two of his mates, “Mikey” and “Stacey”, turned up for some banter. More>>

ALSO:

Auckland & Christchurch: Bob Dylan Returns To NZ

The cross-generational icon will take in Auckland’s Spark Arena on Sunday 26th August and Christchurch’s Horncastle Arena on Tuesday 28th August. More>>

Scoop Review Of Books: Who Killed Jane?

This is an important book. Why? Because any publication that soberly and sensibly attempts to cast light on an unsolved murder is important, for the very real reasons that not only do the bereaved require and deserve a sense of closure, but that the murderer or murderers may be closer to being confirmed, arrested, tried. More>>

Comedy Fest: A Tasty Programme

2018 NZ INTERNATIONAL 26 APRIL – 20 MAY This April and May the 2018 NZ International Comedy Festival with Best Foods Mayo, hits Auckland and Wellington with one of the tastiest comedy line-ups of its 26-year-old history!... More>>

ALSO:

Max Rashbrooke Review: Ravishing Berlioz And Ravel

In this engaging, French-inflected performance, full of strengths, perhaps the standout was the mezzo soprano Sasha Cooke. Wellington has been visited by a few high profile singers recently, notably Anne Sofie von Otter, but few have impressed me as much ... More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland